APO Research
Talk to an analyst

APO RESEARCH · REPORT

Short-acting Nicotine Replacement

Compare research editions
View pricing & licenses

Selected research

Industry Research

Short-acting Nicotine Replacement Industry Research Report 2026

5 June 2026130 pages

Choose your research edition.

Industry ResearchShort-acting Nicotine Replacement Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Short-acting Nicotine Replacement Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Short-acting Nicotine Replacement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Short-acting Nicotine Replacement Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Short-acting Nicotine Replacement Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Short-acting Nicotine Replacement market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Short-acting Nicotine Replacement is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Short-acting Nicotine Replacement is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Short-acting Nicotine Replacement is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Short-acting Nicotine Replacement include Nicorette (Johnson & Johnson), Nicotinell (Haleon), Equate (Walmart), Thrive (Haleon), NiQuitin (Perrigo), Philip Morris, Alkalon, LUCY GOODS and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Short-acting Nicotine Replacement market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Short-acting Nicotine Replacement Market by Company

Nicorette (Johnson & Johnson)

Nicotinell (Haleon)

Equate (Walmart)

Thrive (Haleon)

NiQuitin (Perrigo)

Philip Morris

Alkalon

LUCY GOODS

Dr. Reddy's Laboratories

Nicotex (Cipla Health)

Swedish Match

Altria

British American Tobacco (BAT)

Skruf Snus

Japan Tobacco International (JTI)

Short-acting Nicotine Replacement Segment by Type

Nicotine Gum

Nicotine Lozenge

Nasal Spray

Oral Inhaler

Nicotine Pouches

Short-acting Nicotine Replacement Segment by Application

Online Sales

Offline Sales

Short-acting Nicotine Replacement Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short-acting Nicotine Replacement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short-acting Nicotine Replacement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short-acting Nicotine Replacement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Short-acting Nicotine Replacement manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Short-acting Nicotine Replacement by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Short-acting Nicotine Replacement in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Short-acting Nicotine Replacement Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Short-acting Nicotine Replacement Sales (k units) of Manufacturers (2021-2026) Table 7. Global Short-acting Nicotine Replacement Sales Market Share by Manufacturers (2021-2026) Table 8. Global Short-acting Nicotine Replacement Revenue of Manufacturers (2021-2026) Table 9. Global Short-acting Nicotine Replacement Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Short-acting Nicotine Replacement Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Short-acting Nicotine Replacement Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Short-acting Nicotine Replacement, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Short-acting Nicotine Replacement, Product Type & Application Table 14. Global Short-acting Nicotine Replacement Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Short-acting Nicotine Replacement by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Nicorette (Johnson & Johnson) Company Information Table 19. Nicorette (Johnson & Johnson) Business Overview Table 20. Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Product Portfolio Table 22. Nicorette (Johnson & Johnson) Recent Developments Table 23. Nicotinell (Haleon) Company Information Table 24. Nicotinell (Haleon) Business Overview Table 25. Nicotinell (Haleon) Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Nicotinell (Haleon) Short-acting Nicotine Replacement Product Portfolio Table 27. Nicotinell (Haleon) Recent Developments Table 28. Equate (Walmart) Company Information Table 29. Equate (Walmart) Business Overview Table 30. Equate (Walmart) Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Equate (Walmart) Short-acting Nicotine Replacement Product Portfolio Table 32. Equate (Walmart) Recent Developments Table 33. Thrive (Haleon) Company Information Table 34. Thrive (Haleon) Business Overview Table 35. Thrive (Haleon) Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Thrive (Haleon) Short-acting Nicotine Replacement Product Portfolio Table 37. Thrive (Haleon) Recent Developments Table 38. NiQuitin (Perrigo) Company Information Table 39. NiQuitin (Perrigo) Business Overview Table 40. NiQuitin (Perrigo) Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. NiQuitin (Perrigo) Short-acting Nicotine Replacement Product Portfolio Table 42. NiQuitin (Perrigo) Recent Developments Table 43. Philip Morris Company Information Table 44. Philip Morris Business Overview Table 45. Philip Morris Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Philip Morris Short-acting Nicotine Replacement Product Portfolio Table 47. Philip Morris Recent Developments Table 48. Alkalon Company Information Table 49. Alkalon Business Overview Table 50. Alkalon Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Alkalon Short-acting Nicotine Replacement Product Portfolio Table 52. Alkalon Recent Developments Table 53. LUCY GOODS Company Information Table 54. LUCY GOODS Business Overview Table 55. LUCY GOODS Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. LUCY GOODS Short-acting Nicotine Replacement Product Portfolio Table 57. LUCY GOODS Recent Developments Table 58. Dr. Reddy's Laboratories Company Information Table 59. Dr. Reddy's Laboratories Business Overview Table 60. Dr. Reddy's Laboratories Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Dr. Reddy's Laboratories Short-acting Nicotine Replacement Product Portfolio Table 62. Dr. Reddy's Laboratories Recent Developments Table 63. Nicotex (Cipla Health) Company Information Table 64. Nicotex (Cipla Health) Business Overview Table 65. Nicotex (Cipla Health) Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Nicotex (Cipla Health) Short-acting Nicotine Replacement Product Portfolio Table 67. Nicotex (Cipla Health) Recent Developments Table 68. Swedish Match Company Information Table 69. Swedish Match Business Overview Table 70. Swedish Match Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Swedish Match Short-acting Nicotine Replacement Product Portfolio Table 72. Swedish Match Recent Developments Table 73. Altria Company Information Table 74. Altria Business Overview Table 75. Altria Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Altria Short-acting Nicotine Replacement Product Portfolio Table 77. Altria Recent Developments Table 78. British American Tobacco (BAT) Company Information Table 79. British American Tobacco (BAT) Business Overview Table 80. British American Tobacco (BAT) Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. British American Tobacco (BAT) Short-acting Nicotine Replacement Product Portfolio Table 82. British American Tobacco (BAT) Recent Developments Table 83. Skruf Snus Company Information Table 84. Skruf Snus Business Overview Table 85. Skruf Snus Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Skruf Snus Short-acting Nicotine Replacement Product Portfolio Table 87. Skruf Snus Recent Developments Table 88. Japan Tobacco International (JTI) Company Information Table 89. Japan Tobacco International (JTI) Business Overview Table 90. Japan Tobacco International (JTI) Short-acting Nicotine Replacement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Japan Tobacco International (JTI) Short-acting Nicotine Replacement Product Portfolio Table 92. Japan Tobacco International (JTI) Recent Developments Table 93. Global Short-acting Nicotine Replacement Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Short-acting Nicotine Replacement Sales by Region (2021-2026) & (k units) Table 95. Global Short-acting Nicotine Replacement Sales Market Share by Region (2021-2026) Table 96. Global Short-acting Nicotine Replacement Sales by Region (2027-2032) & (k units) Table 97. Global Short-acting Nicotine Replacement Sales Market Share by Region (2027-2032) Table 98. Global Short-acting Nicotine Replacement Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Short-acting Nicotine Replacement Revenue Market Share by Region (2021-2026) Table 100. Global Short-acting Nicotine Replacement Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Short-acting Nicotine Replacement Revenue Market Share by Region (2027-2032) Table 102. North America Short-acting Nicotine Replacement Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Short-acting Nicotine Replacement Sales by Country (2021-2026) & (k units) Table 104. North America Short-acting Nicotine Replacement Sales by Country (2027-2032) & (k units) Table 105. North America Short-acting Nicotine Replacement Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Short-acting Nicotine Replacement Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Short-acting Nicotine Replacement Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Short-acting Nicotine Replacement Sales by Country (2021-2026) & (k units) Table 109. Europe Short-acting Nicotine Replacement Sales by Country (2027-2032) & (k units) Table 110. Europe Short-acting Nicotine Replacement Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Short-acting Nicotine Replacement Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Short-acting Nicotine Replacement Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Short-acting Nicotine Replacement Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Short-acting Nicotine Replacement Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Short-acting Nicotine Replacement Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Short-acting Nicotine Replacement Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Short-acting Nicotine Replacement Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Short-acting Nicotine Replacement Sales by Country (2021-2026) & (k units) Table 119. South America Short-acting Nicotine Replacement Sales by Country (2027-2032) & (k units) Table 120. South America Short-acting Nicotine Replacement Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Short-acting Nicotine Replacement Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Short-acting Nicotine Replacement Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Short-acting Nicotine Replacement Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Short-acting Nicotine Replacement Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Short-acting Nicotine Replacement Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Short-acting Nicotine Replacement Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Short-acting Nicotine Replacement Sales by Type (2021-2026) & (k units) Table 128. Global Short-acting Nicotine Replacement Sales by Type (2027-2032) & (k units) Table 129. Global Short-acting Nicotine Replacement Sales Market Share by Type (2021-2026) Table 130. Global Short-acting Nicotine Replacement Sales Market Share by Type (2027-2032) Table 131. Global Short-acting Nicotine Replacement Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Short-acting Nicotine Replacement Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Short-acting Nicotine Replacement Revenue Market Share by Type (2021-2026) Table 134. Global Short-acting Nicotine Replacement Revenue Market Share by Type (2027-2032) Table 135. Global Short-acting Nicotine Replacement Price by Type (2021-2026) & (USD/unit) Table 136. Global Short-acting Nicotine Replacement Price by Type (2027-2032) & (USD/unit) Table 137. Global Short-acting Nicotine Replacement Sales by Application (2021-2026) & (k units) Table 138. Global Short-acting Nicotine Replacement Sales by Application (2027-2032) & (k units) Table 139. Global Short-acting Nicotine Replacement Sales Market Share by Application (2021-2026) Table 140. Global Short-acting Nicotine Replacement Sales Market Share by Application (2027-2032) Table 141. Global Short-acting Nicotine Replacement Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Short-acting Nicotine Replacement Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Short-acting Nicotine Replacement Revenue Market Share by Application (2021-2026) Table 144. Global Short-acting Nicotine Replacement Revenue Market Share by Application (2027-2032) Table 145. Global Short-acting Nicotine Replacement Price by Application (2021-2026) & (USD/unit) Table 146. Global Short-acting Nicotine Replacement Price by Application (2027-2032) & (USD/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Short-acting Nicotine Replacement Distributors List Table 150. Short-acting Nicotine Replacement Customers List Table 151. Short-acting Nicotine Replacement Industry Trends Table 152. Short-acting Nicotine Replacement Industry Drivers Table 153. Short-acting Nicotine Replacement Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Short-acting Nicotine Replacement Product Image Figure 5. Global Short-acting Nicotine Replacement Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Short-acting Nicotine Replacement Market Size (2021-2032) & (US$ Million) Figure 7. Global Short-acting Nicotine Replacement Sales (2021-2032) & (k units) Figure 8. Global Short-acting Nicotine Replacement Average Price (USD/unit) & (2021-2032) Figure 9. Nicotine Gum Product Image Figure 10. Nicotine Lozenge Product Image Figure 11. Nasal Spray Product Image Figure 12. Oral Inhaler Product Image Figure 13. Nicotine Pouches Product Image Figure 14. Online Sales Product Image Figure 15. Offline Sales Product Image Figure 16. Global Short-acting Nicotine Replacement Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Short-acting Nicotine Replacement, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Short-acting Nicotine Replacement Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Short-acting Nicotine Replacement Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Short-acting Nicotine Replacement Sales by Region in 2025 Figure 22. Global Short-acting Nicotine Replacement Revenue by Region in 2025 Figure 23. North America Short-acting Nicotine Replacement Market Size by Country in 2025 Figure 24. North America Short-acting Nicotine Replacement Sales Market Share by Country (2021-2032) Figure 25. North America Short-acting Nicotine Replacement Revenue Market Share by Country (2021-2032) Figure 26. United States Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Short-acting Nicotine Replacement Market Size by Country in 2025 Figure 30. Europe Short-acting Nicotine Replacement Sales Market Share by Country (2021-2032) Figure 31. Europe Short-acting Nicotine Replacement Revenue Market Share by Country (2021-2032) Figure 32. Germany Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Short-acting Nicotine Replacement Market Size by Country in 2025 Figure 43. Asia Pacific Short-acting Nicotine Replacement Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Short-acting Nicotine Replacement Revenue Market Share by Country (2021-2032) Figure 45. China Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Short-acting Nicotine Replacement Market Size by Country in 2025 Figure 54. South America Short-acting Nicotine Replacement Sales Market Share by Country (2021-2032) Figure 55. South America Short-acting Nicotine Replacement Revenue Market Share by Country (2021-2032) Figure 56. Brazil Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Short-acting Nicotine Replacement Market Size by Country in 2025 Figure 60. Middle East and Africa Short-acting Nicotine Replacement Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Short-acting Nicotine Replacement Revenue Market Share by Country (2021-2032) Figure 62. Egypt Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Short-acting Nicotine Replacement Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Short-acting Nicotine Replacement Sales Market Share by Type (2021-2032) Figure 68. Global Short-acting Nicotine Replacement Revenue Market Share by Type (2021-2032) Figure 69. Global Short-acting Nicotine Replacement Price (USD/unit) by Type (2021-2032) Figure 70. Global Short-acting Nicotine Replacement Sales Market Share by Application (2021-2032) Figure 71. Global Short-acting Nicotine Replacement Revenue Market Share by Application (2021-2032) Figure 72. Global Short-acting Nicotine Replacement Price (USD/unit) by Application (2021-2032) Figure 73. Short-acting Nicotine Replacement Value Chain Figure 74. Short-acting Nicotine Replacement Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Short-acting Nicotine Replacement Industry Opportunities and Challenges

Scope & coverage.

Types
  • Nicotine Gum
  • Nicotine Lozenge
  • Nasal Spray
  • Oral Inhaler
  • Nicotine Pouches
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Nicorette (Johnson & Johnson)
  • Nicotinell (Haleon)
  • Equate (Walmart)
  • Thrive (Haleon)
  • NiQuitin (Perrigo)
  • Philip Morris
  • Alkalon
  • LUCY GOODS
  • Dr. Reddy's Laboratories
  • Nicotex (Cipla Health)
  • Swedish Match
  • Altria
  • British American Tobacco (BAT)
  • Skruf Snus
  • Japan Tobacco International (JTI)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Short-acting Nicotine Replacement Market Size (2021-2032)
  4. 2.2.2 Global Short-acting Nicotine Replacement Sales (2021-2032)
  5. 2.2.3 Global Short-acting Nicotine Replacement Market Average Price (2021-2032)
  6. 2.3 Short-acting Nicotine Replacement by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Nicotine Gum
  9. 2.3.3 Nicotine Lozenge
  10. 2.3.4 Nasal Spray
  11. 2.3.5 Oral Inhaler
  12. 2.3.6 Nicotine Pouches
  13. 2.4 Short-acting Nicotine Replacement by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Online Sales
  16. 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Short-acting Nicotine Replacement Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Short-acting Nicotine Replacement Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Short-acting Nicotine Replacement Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Short-acting Nicotine Replacement Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Short-acting Nicotine Replacement Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Short-acting Nicotine Replacement, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Short-acting Nicotine Replacement, Product Type & Application
  8. 3.8 Global Manufacturers of Short-acting Nicotine Replacement, Established Date
  9. 3.9 Global Short-acting Nicotine Replacement Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Nicorette (Johnson & Johnson)
  2. 4.1.1 Nicorette (Johnson & Johnson) Company Information
  3. 4.1.2 Nicorette (Johnson & Johnson) Business Overview
  4. 4.1.3 Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Product Portfolio
  6. 4.1.5 Nicorette (Johnson & Johnson) Recent Developments
  7. 4.2 Nicotinell (Haleon)
  8. 4.2.1 Nicotinell (Haleon) Company Information
  9. 4.2.2 Nicotinell (Haleon) Business Overview
  10. 4.2.3 Nicotinell (Haleon) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Nicotinell (Haleon) Short-acting Nicotine Replacement Product Portfolio
  12. 4.2.5 Nicotinell (Haleon) Recent Developments
  13. 4.3 Equate (Walmart)
  14. 4.3.1 Equate (Walmart) Company Information
  15. 4.3.2 Equate (Walmart) Business Overview
  16. 4.3.3 Equate (Walmart) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Equate (Walmart) Short-acting Nicotine Replacement Product Portfolio
  18. 4.3.5 Equate (Walmart) Recent Developments
  19. 4.4 Thrive (Haleon)
  20. 4.4.1 Thrive (Haleon) Company Information
  21. 4.4.2 Thrive (Haleon) Business Overview
  22. 4.4.3 Thrive (Haleon) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Thrive (Haleon) Short-acting Nicotine Replacement Product Portfolio
  24. 4.4.5 Thrive (Haleon) Recent Developments
  25. 4.5 NiQuitin (Perrigo)
  26. 4.5.1 NiQuitin (Perrigo) Company Information
  27. 4.5.2 NiQuitin (Perrigo) Business Overview
  28. 4.5.3 NiQuitin (Perrigo) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 NiQuitin (Perrigo) Short-acting Nicotine Replacement Product Portfolio
  30. 4.5.5 NiQuitin (Perrigo) Recent Developments
  31. 4.6 Philip Morris
  32. 4.6.1 Philip Morris Company Information
  33. 4.6.2 Philip Morris Business Overview
  34. 4.6.3 Philip Morris Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Philip Morris Short-acting Nicotine Replacement Product Portfolio
  36. 4.6.5 Philip Morris Recent Developments
  37. 4.7 Alkalon
  38. 4.7.1 Alkalon Company Information
  39. 4.7.2 Alkalon Business Overview
  40. 4.7.3 Alkalon Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Alkalon Short-acting Nicotine Replacement Product Portfolio
  42. 4.7.5 Alkalon Recent Developments
  43. 4.8 LUCY GOODS
  44. 4.8.1 LUCY GOODS Company Information
  45. 4.8.2 LUCY GOODS Business Overview
  46. 4.8.3 LUCY GOODS Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 LUCY GOODS Short-acting Nicotine Replacement Product Portfolio
  48. 4.8.5 LUCY GOODS Recent Developments
  49. 4.9 Dr. Reddy's Laboratories
  50. 4.9.1 Dr. Reddy's Laboratories Company Information
  51. 4.9.2 Dr. Reddy's Laboratories Business Overview
  52. 4.9.3 Dr. Reddy's Laboratories Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Dr. Reddy's Laboratories Short-acting Nicotine Replacement Product Portfolio
  54. 4.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 4.10 Nicotex (Cipla Health)
  56. 4.10.1 Nicotex (Cipla Health) Company Information
  57. 4.10.2 Nicotex (Cipla Health) Business Overview
  58. 4.10.3 Nicotex (Cipla Health) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Nicotex (Cipla Health) Short-acting Nicotine Replacement Product Portfolio
  60. 4.10.5 Nicotex (Cipla Health) Recent Developments
  61. 4.11 Swedish Match
  62. 4.11.1 Swedish Match Company Information
  63. 4.11.2 Swedish Match Business Overview
  64. 4.11.3 Swedish Match Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Swedish Match Short-acting Nicotine Replacement Product Portfolio
  66. 4.11.5 Swedish Match Recent Developments
  67. 4.12 Altria
  68. 4.12.1 Altria Company Information
  69. 4.12.2 Altria Business Overview
  70. 4.12.3 Altria Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Altria Short-acting Nicotine Replacement Product Portfolio
  72. 4.12.5 Altria Recent Developments
  73. 4.13 British American Tobacco (BAT)
  74. 4.13.1 British American Tobacco (BAT) Company Information
  75. 4.13.2 British American Tobacco (BAT) Business Overview
  76. 4.13.3 British American Tobacco (BAT) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 British American Tobacco (BAT) Short-acting Nicotine Replacement Product Portfolio
  78. 4.13.5 British American Tobacco (BAT) Recent Developments
  79. 4.14 Skruf Snus
  80. 4.14.1 Skruf Snus Company Information
  81. 4.14.2 Skruf Snus Business Overview
  82. 4.14.3 Skruf Snus Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Skruf Snus Short-acting Nicotine Replacement Product Portfolio
  84. 4.14.5 Skruf Snus Recent Developments
  85. 4.15 Japan Tobacco International (JTI)
  86. 4.15.1 Japan Tobacco International (JTI) Company Information
  87. 4.15.2 Japan Tobacco International (JTI) Business Overview
  88. 4.15.3 Japan Tobacco International (JTI) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Japan Tobacco International (JTI) Short-acting Nicotine Replacement Product Portfolio
  90. 4.15.5 Japan Tobacco International (JTI) Recent Developments
5 Global Short-acting Nicotine Replacement Market Scenario by Region
  1. 5.1 Global Short-acting Nicotine Replacement Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Short-acting Nicotine Replacement Sales by Region: 2021-2032
  3. 5.2.1 Global Short-acting Nicotine Replacement Sales by Region: 2021-2026
  4. 5.2.2 Global Short-acting Nicotine Replacement Sales by Region: 2027-2032
  5. 5.3 Global Short-acting Nicotine Replacement Revenue by Region: 2021-2032
  6. 5.3.1 Global Short-acting Nicotine Replacement Revenue by Region: 2021-2026
  7. 5.3.2 Global Short-acting Nicotine Replacement Revenue by Region: 2027-2032
  8. 5.4 North America Short-acting Nicotine Replacement Market Facts & Figures by Country
  9. 5.4.1 North America Short-acting Nicotine Replacement Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Short-acting Nicotine Replacement Sales by Country (2021-2032)
  11. 5.4.3 North America Short-acting Nicotine Replacement Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Short-acting Nicotine Replacement Market Facts & Figures by Country
  16. 5.5.1 Europe Short-acting Nicotine Replacement Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Short-acting Nicotine Replacement Sales by Country (2021-2032)
  18. 5.5.3 Europe Short-acting Nicotine Replacement Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Short-acting Nicotine Replacement Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Short-acting Nicotine Replacement Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Short-acting Nicotine Replacement Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Short-acting Nicotine Replacement Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Short-acting Nicotine Replacement Market Facts & Figures by Country
  41. 5.7.1 South America Short-acting Nicotine Replacement Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Short-acting Nicotine Replacement Sales by Country (2021-2032)
  43. 5.7.3 South America Short-acting Nicotine Replacement Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Short-acting Nicotine Replacement Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Short-acting Nicotine Replacement Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Short-acting Nicotine Replacement Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Short-acting Nicotine Replacement Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Short-acting Nicotine Replacement Sales by Type (2021-2032)
  2. 6.1.1 Global Short-acting Nicotine Replacement Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Short-acting Nicotine Replacement Sales Market Share by Type (2021-2032)
  4. 6.2 Global Short-acting Nicotine Replacement Revenue by Type (2021-2032)
  5. 6.2.1 Global Short-acting Nicotine Replacement Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Short-acting Nicotine Replacement Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Short-acting Nicotine Replacement Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Short-acting Nicotine Replacement Sales by Application (2021-2032)
  2. 7.1.1 Global Short-acting Nicotine Replacement Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Short-acting Nicotine Replacement Sales Market Share by Application (2021-2032)
  4. 7.2 Global Short-acting Nicotine Replacement Revenue by Application (2021-2032)
  5. 7.2.1 Global Short-acting Nicotine Replacement Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Short-acting Nicotine Replacement Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Short-acting Nicotine Replacement Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Short-acting Nicotine Replacement Value Chain Analysis
  2. 8.1.1 Short-acting Nicotine Replacement Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Short-acting Nicotine Replacement Production Mode & Process
  5. 8.2 Short-acting Nicotine Replacement Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Short-acting Nicotine Replacement Distributors
  8. 8.2.3 Short-acting Nicotine Replacement Customers
9 Global Short-acting Nicotine Replacement Analyzing Market Dynamics
  1. 9.1 Short-acting Nicotine Replacement Industry Trends
  2. 9.2 Short-acting Nicotine Replacement Industry Drivers
  3. 9.3 Short-acting Nicotine Replacement Industry Opportunities and Challenges
  4. 9.4 Short-acting Nicotine Replacement Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst